87 related articles for article (PubMed ID: 11563077)
1. Anti-HBV specific beta-L-2'-deoxynucleosides.
Bryant ML; Bridges EG; Placidi L; Faraj A; Loi AG; Pierra C; Dukhan D; Gosselin G; Imbach JL; Hernandez B; Juodawlkis A; Tennant B; Korba B; Cote P; Cretton-Scott E; Schinazi RF; Sommadossi JP
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):597-607. PubMed ID: 11563077
[TBL] [Abstract][Full Text] [Related]
2. Antiviral L-nucleosides specific for hepatitis B virus infection.
Bryant ML; Bridges EG; Placidi L; Faraj A; Loi AG; Pierra C; Dukhan D; Gosselin G; Imbach JL; Hernandez B; Juodawlkis A; Tennant B; Korba B; Cote P; Marion P; Cretton-Scott E; Schinazi RF; Sommadossi JP
Antimicrob Agents Chemother; 2001 Jan; 45(1):229-35. PubMed ID: 11120971
[TBL] [Abstract][Full Text] [Related]
3. Effect of various pyrimidines possessing the 1-[(2-hydroxy-1-(hydroxymethyl)ethoxy)methyl] moiety, able to mimic natural 2'-deoxyribose, on wild-type and mutant hepatitis B virus replication.
Kumar R; Semaine W; Johar M; Tyrrell DL; Agrawal B
J Med Chem; 2006 Jun; 49(12):3693-700. PubMed ID: 16759112
[TBL] [Abstract][Full Text] [Related]
4. Enhanced antiviral benefit of combination therapy with lamivudine and alpha interferon against WHV replication in chronic carrier woodchucks.
Korba BE; Cote P; Hornbuckle W; Schinazi R; Gangemi JD; Tennant BC; Gerin JL
Antivir Ther; 2000 Jun; 5(2):95-104. PubMed ID: 10971862
[TBL] [Abstract][Full Text] [Related]
5. Antiviral beta-L-nucleosides specific for hepatitis B virus infection.
Standring DN; Bridges EG; Placidi L; Faraj A; Loi AG; Pierra C; Dukhan D; Gosselin G; Imbach JL; Hernandez B; Juodawlkis A; Tennant B; Korba B; Cote P; Cretton-Scott E; Schinazi RF; Myers M; Bryant ML; Sommadossi JP
Antivir Chem Chemother; 2001; 12 Suppl 1():119-29. PubMed ID: 11594678
[TBL] [Abstract][Full Text] [Related]
6. Antiviral activity of various 1-(2'-deoxy-β-D-lyxofuranosyl), 1-(2'-fluoro-β-D-xylofuranosyl), 1-(3'-fluoro-β-D-arabinofuranosyl), and 2'-fluoro-2',3'-didehydro-2',3'-dideoxyribose pyrimidine nucleoside analogues against duck hepatitis B virus (DHBV) and human hepatitis B virus (HBV) replication.
Srivastav NC; Shakya N; Mak M; Agrawal B; Tyrrell DL; Kumar R
J Med Chem; 2010 Oct; 53(19):7156-66. PubMed ID: 20857959
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of novel strategies to combat hepatitis B virus targetting wild-type and drug-resistant mutants in experimental models.
Zoulim F
Antivir Chem Chemother; 2001; 12 Suppl 1():131-42. PubMed ID: 11594680
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of hepatitis B virus DNA polymerase by enantiomers of penciclovir triphosphate and metabolic basis for selective inhibition of HBV replication by penciclovir.
Shaw T; Mok SS; Locarnini SA
Hepatology; 1996 Nov; 24(5):996-1002. PubMed ID: 8903366
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus replication and liver disease progression: the impact of antiviral therapy.
Liaw YF
Antivir Ther; 2006; 11(6):669-79. PubMed ID: 17310811
[TBL] [Abstract][Full Text] [Related]
10. A multi-center open study to determine the effect of lamivudine on HBV DNA clearance and to assess the safety of the regimen in patients with chronic hepatitis B infection.
Mazur W; Król F; Cianciara J; Nazzal K; Gładysz A; Juszczyk J; Bolewska B; Adamek J; Czajka B; Swietek K; Kryczka W; Gonciarz Z
Med Sci Monit; 2002 Apr; 8(4):CR257-62. PubMed ID: 11951067
[TBL] [Abstract][Full Text] [Related]
11. Strong and selective inhibitors of hepatitis B virus replication among novel N4-hydroxy- and 5-methyl-beta-L-deoxycytidine analogues.
Matthes E; Funk A; Krahn I; Gaertner K; von Janta-Lipinski M; Lin L; Will H; Sirma H
Antimicrob Agents Chemother; 2007 Jul; 51(7):2523-30. PubMed ID: 17404006
[TBL] [Abstract][Full Text] [Related]
12. [Synthesis of a novel L-nucleoside, beta-L-D4A and its inhibition on the replication of hepatitis B virus in vitro].
Wu JM; Lin JS; Xie N; Qiu GF; Hu XM
Yao Xue Xue Bao; 2005 Sep; 40(9):825-9. PubMed ID: 16342685
[TBL] [Abstract][Full Text] [Related]
13. Sulfamoylbenzamide derivatives inhibit the assembly of hepatitis B virus nucleocapsids.
Campagna MR; Liu F; Mao R; Mills C; Cai D; Guo F; Zhao X; Ye H; Cuconati A; Guo H; Chang J; Xu X; Block TM; Guo JT
J Virol; 2013 Jun; 87(12):6931-42. PubMed ID: 23576513
[TBL] [Abstract][Full Text] [Related]
14. Does the anti-hepatitis B virus activity of (+)-5'-noraristeromycin exist in its 4'-epimer and 4'-deoxygenated derivatives?
Seley KL; Schneller SW; Korba B
J Med Chem; 1998 Jun; 41(12):2168-70. PubMed ID: 9622558
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of hepatitis B virus (HBV) replication by pyrimidines bearing an acyclic moiety: effect on wild-type and mutant HBV.
Semaine W; Johar M; Tyrrell DL; Kumar R; Agrawal B
J Med Chem; 2006 Mar; 49(6):2049-54. PubMed ID: 16539393
[TBL] [Abstract][Full Text] [Related]
16. Antisense oligonucleotides targeted against asialoglycoprotein receptor 1 block human hepatitis B virus replication.
Yang J; Bo XC; Ding XR; Dai JM; Zhang ML; Wang XH; Wang SQ
J Viral Hepat; 2006 Mar; 13(3):158-65. PubMed ID: 16475991
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of viral persistence and resistance to nucleoside and nucleotide analogs in chronic hepatitis B virus infection.
Zoulim F
Antiviral Res; 2004 Oct; 64(1):1-15. PubMed ID: 15451174
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, biological evaluation and structure-activity relationships of glycyrrhetinic acid derivatives as novel anti-hepatitis B virus agents.
Wang LJ; Geng CA; Ma YB; Huang XY; Luo J; Chen H; Zhang XM; Chen JJ
Bioorg Med Chem Lett; 2012 May; 22(10):3473-9. PubMed ID: 22520261
[TBL] [Abstract][Full Text] [Related]
19. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antiviral activity of new acrylamide derivatives containing 1,2,3-thiadiazole as inhibitors of hepatitis B virus replication.
Dong WL; Liu ZX; Liu XH; Li ZM; Zhao WG
Eur J Med Chem; 2010 May; 45(5):1919-26. PubMed ID: 20149495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]